BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34284647)

  • 1. Associated mood changes with naloxegol therapy for opioid-induced constipation in a patient with psychiatric disease.
    Nagda N; Javed S
    Pain Manag; 2022 Jan; 12(1):13-16. PubMed ID: 34284647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised clinical trial: the long-term safety and tolerability of naloxegol in patients with pain and opioid-induced constipation.
    Webster L; Chey WD; Tack J; Lappalainen J; Diva U; Sostek M
    Aliment Pharmacol Ther; 2014 Oct; 40(7):771-9. PubMed ID: 25112584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxegol for opioid-induced constipation in patients with noncancer pain.
    Chey WD; Webster L; Sostek M; Lappalainen J; Barker PN; Tack J
    N Engl J Med; 2014 Jun; 370(25):2387-96. PubMed ID: 24896818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating naloxegol for the treatment of opioid-induced constipation.
    Daniali M; Nikfar S; Abdollahi M
    Expert Opin Pharmacother; 2020 Jun; 21(8):883-891. PubMed ID: 32129103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular Safety of the Selective μ-Opioid Receptor Antagonist Naloxegol: A Novel Therapy for Opioid-Induced Constipation.
    White WB; Kowey P; Diva U; Sostek M; Tummala R
    J Cardiovasc Pharmacol Ther; 2018 Jul; 23(4):309-317. PubMed ID: 29504415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation.
    Lemaire A; Pointreau Y; Narciso B; Piloquet FX; Braniste V; Sabaté JM
    Support Care Cancer; 2021 Dec; 29(12):7577-7586. PubMed ID: 34120247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation.
    Webster L; Tummala R; Diva U; Lappalainen J
    J Opioid Manag; 2016; 12(6):405-419. PubMed ID: 28059433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost Effectiveness of Naloxegol for Opioid-Induced Constipation in the UK.
    Lawson R; Ryan J; King F; Goh JW; Tichy E; Marsh K
    Pharmacoeconomics; 2017 Feb; 35(2):225-235. PubMed ID: 27663572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxegol to Treat Constipation in a Patient Taking Opioids for Cancer Pain: A Case Report.
    Gálvez R; Maire C; Tovar I; Vargas P
    A A Pract; 2018 Jul; 11(1):22-24. PubMed ID: 29634552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxegol: a review of its use in patients with opioid-induced constipation.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxegol: treatment for opioid-induced constipation in chronic non-cancer pain.
    Leonard J; Baker DE
    Ann Pharmacother; 2015 Mar; 49(3):360-5. PubMed ID: 25471070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute opioid withdrawal syndrome from naloxone/naloxegol interaction.
    Olmo M; González-Barboteo J; Moreno D; Coma E; Serrano G
    BMJ Support Palliat Care; 2021 Dec; 11(4):408-410. PubMed ID: 32788278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Opioid-induced constipation in oncologic patient: a clinical case treated with naloxegol].
    Gallo P
    Recenti Prog Med; 2019 Mar; 110(3):6e-9e. PubMed ID: 30968858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naloxegol for the treatment of opioid-induced constipation.
    Tack J; Corsetti M
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):855-61. PubMed ID: 25220391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxegol: A Novel Therapy in the Management of Opioid-Induced Constipation.
    Jones R; Prommer E; Backstedt D
    Am J Hosp Palliat Care; 2016 Nov; 33(9):875-880. PubMed ID: 26150678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with Naloxegol Versus Placebo: Pain Assessment in Patients with Noncancer Pain and Opioid-Induced Constipation.
    Webster L; Diva U; Tummala R; Sostek M
    Pain Pract; 2018 Apr; 18(4):505-514. PubMed ID: 28898536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of naloxegol on anal sphincter function - Using a human experimental model of opioid-induced bowel dysfunction.
    Grønlund D; Poulsen JL; Krogh K; Brock C; Liao D; Gregersen H; Drewes AM; Olesen AE
    Eur J Pharm Sci; 2018 May; 117():187-192. PubMed ID: 29432808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naloxegol for managing opioid-induced constipation.
    Shelton KN; Clements JN
    JAAPA; 2017 Sep; 30(9):51-53. PubMed ID: 28858018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ▼Naloxegol for opioid-induced constipation.
    Drug Ther Bull; 2015 Dec; 53(12):138-40. PubMed ID: 26660436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Treatment with Naloxegol for Opioid-Induced Constipation on Patients' Health State Utility.
    Lawson R; King F; Marsh K; Altincatal A; Cimen A
    Adv Ther; 2016 Aug; 33(8):1331-46. PubMed ID: 27342744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.